SCHEMBL7403121

SCHEMBL7403121

O=C(Cc1ccccc1)Cc1ccc(Cl)c(Cl)c1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 4/20 0.51
HTT P42858 2/20 0.50
TRPV1 Q8NER1 1/20 0.50
CA2 P00918 2/20 0.49
PLAAT3 P53816 1/20 0.49
PLAAT5 Q96KN8 1/20 0.49
PLAAT2 Q9NWW9 1/20 0.49
PLAAT4 Q9UL19 1/20 0.49
CA1 P00915 1/20 0.49
HSD17B2 P37059 1/20 0.49
PTPRG P23470 1/20 0.49
PIK3CA P42336 1/20 0.49
PDPK1 O15530 1/20 0.48
KMT2A Q03164 1/20 0.47
CES2 O00748 1/20 0.47
CES1 P23141 1/20 0.47
CASP3 P42574 1/20 0.47
CASP7 P55210 1/20 0.47
AKR1B1 P15121 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23792517 0.86 TDP1 (0.59) SIGMAR1HTTTRPV1CA2PLAAT3
SCHEMBL8065181 0.84 MGAM (0.48) HTTCA2PTPRGPIK3CAKMT2A
SCHEMBL2251905 0.81 PIK3CA (0.51) SIGMAR1HTTCA2PIK3CAKMT2A
SCHEMBL283587 0.80 CA2 (0.71) CA2PIK3CAKMT2AAKR1B1
SCHEMBL8406795 0.80 L3MBTL1 (0.66) SIGMAR1KMT2ACES2CES1AKR1B1
SCHEMBL1515710 0.80 S1PR5 (0.59) SIGMAR1CA2PTPRGPIK3CAPDPK1
SCHEMBL77563 0.79 CES1 (0.70) HTTKMT2ACES2CES1AKR1B1
SCHEMBL823446 0.79 PNMT (0.52) SIGMAR1CA2PIK3CAKMT2A
SCHEMBL8376663 0.79 TSHR (0.50) CA2PIK3CAKMT2A
SCHEMBL1351021 0.79 PIK3CA (0.50) SIGMAR1HTTCA2PIK3CAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6323240-B1 HALOGENATED DERIVATIVES AS ENZYME INHIBITORS PHARMACIA & UPJOHN S.P.A. (IT) 2001-11-27 US disclosed
US-6048896-A FOR TREATMENT OF BRAIN OR NERVOUS SYSTEM DISORDERS PHARMACIA & UPJOHN S.P.A. (IT) 2000-04-11 US disclosed
EP-0858443-A1 4-PHENYL-4-OXO-BUTANOIC ACID DERIVATIVES WITH KYNURENINE-3-HYDROXYLASE INHIBITING ACTIVITY PHARMACIA & UPJOHN S.p.A. (IT) 1998-08-19 EP disclosed
EP-0858442-A1 4-PHENYL-4-OXO-2-BUTENOIC ACID DERIVATIVES WITH KYNURENINE-3-HYDROXYLASE INHIBITING ACTIVITY PHARMACIA & UPJOHN S.p.A. (IT) 1998-08-19 EP disclosed
WO-1997017316-A1 4-PHENYL-4-OXO-2-BUTENOIC ACID DERIVATIVES WITH KYNURENINE-3-HYDROXYLASE INHIBITING ACTIVITY PHARMACIA & UPJOHN S.P.A. (IT) 1997-05-15 WO disclosed
WO-1997017317-A1 4-PHENYL-4-OXO-BUTANOIC ACID DERIVATIVES WITH KYNURENINE-3-HYDROXYLASE INHIBITING ACTIVITY PHARMACIA & UPJOHN S.P.A. (IT) 1997-05-15 WO disclosed